Dipeptidyl peptidase-4 inhibitor linagliptin improves fibrosis, apoptosis, and cardiac function in a large animal model of chronic myocardial ischemia

Authors

Dwight D. Harris
Christopher Stone
Mark Broadwin MD, Lehigh Valley Health NetworkFollow
Meghamsh Kanuparthy
Sharif A. Sabe
Ju-Woo Nho
Jad Hamze
M Ruhul Abid
Frank W. Sellke

Publication/Presentation Date

2-2025

Volume

392

Issue

2

First Page

100532

Last Page

100532

Published In/Presented At

Harris, D.D., Stone, C., Broadwin, M., Kanuparthy, M., Sabe, S.A., Nho, J.W., Hamze, J., Abid, M.R., & Sellke, F.W. (2025, Feb). Dipeptidyl peptidase-4 inhibitor linagliptin improves fibrosis, apoptosis, and cardiac function in a large animal model of chronic myocardial ischemia. The Journal of Pharmacology and Experimental Therapeutics, 392(2), 100532.

Disciplines

Medicine and Health Sciences

Department(s)

Department of Surgery, Fellows and Residents

Document Type

Article